Pharmacy and Poisons Board (PPB),Pharmacy and Poisons Board suspends licenses of four pharmaceutical practitioners Stories
In particular, the Board has flagged products listed under Indian Pharmacopoeia, warning that they do not meet the country’s drug registration require...
The PPB directed pharmaceutical outlets and health facilities to withhold the affected batch pending further investigations.
The Pharmacy and Poisons Board (PPB) announced the move on Wednesday, after detecting suspected contamination with Diethylene Glycol (DEG) and Ethylen...
In a statement on Wednesday, the PPB expressed concern that the unregistered and substandard version of this critical drug poses significant risks to...
All healthcare practitioners and dispensing pharmacies directed to immediately stop the use and sale of the batch.
The Board further advised all pharmacies, hospitals, and members of the public to immediately stop selling or purchasing the recalled batch.
Kaluai said despite regular audits of wholesalers, some continue to operate without proper licensing, compromising patients' safety.
The PPB’s intensified oversight comes soon after it launched Kenya’s first monitoring framework for antimicrobial drug consumption, targeting antibiot...
According to a 2019 survey by the Institute for Health Metrics and Evaluation, antimicrobial resistance was responsible for approximately 8,500 deaths...
The Board's Enquiries and Disciplinary Committee (EDC) had taken action against these practitioners.
The Board emphasised that it remains committed to protecting the health of the public.
WHO has identified antimicrobial resistance as a major global health concern, directly attributing 1.3 million deaths to it.
Chief Executive Officer of PPB Fred Siyoi, warned that health products and technologies obtained outside of the regulated supply chain risk public and...
The public is encouraged to report any encounters with such counterfeit products to the nearest healthcare facility or directly to the Pharmacy and Po...
During the four-day operation, teams from both countries inspected shipments of health products arriving via postal and air cargo.
The stolen pharmaceuticals were found in unlicensed chemists, posing serious health risks to the public due to their unregulated handling and distribu...
The PPB strongly advised against the use, distribution, sale, or supply of the C5830083 batch due to its inability to guarantee its safety, quality, a...
The call came after an operation saw 21 pharmacies shut down in Mombasa last week for illegally selling Rohypnol.
Thirty-six individuals have been apprehended, with legal actions commenced against several others, including 7 in Nairobi, 19 in Central Kenya, and 10...
The affected batches were sold in six countries including Kenya, South Africa, Eswatini, Rwanda, Tanzania and Nigeria.
